Endoglin (CD105) as a urinary and serum marker of prostate cancer
about
Current status of biomarkers for prostate cancerEndoglin in liver fibrogenesis: Bridging basic science and clinical practiceEndoglin suppresses human prostate cancer metastasis.Angiogenesis and lymphangiogenesis in the spectrum of leprosy and its reactional forms.Tumor markers in prostate cancer I: blood-based markers.Toward the detection of prostate cancer in urine: a critical analysis.Endoglin for tumor imaging and targeted cancer therapy.Urine markers and prostate cancerRecent progress in urinary proteome analysis for prostate cancer diagnosis and management.The role of cancer stem cells in tumor heterogeneity and resistance to therapy.Quantitative urinary proteomics using stable isotope labelling by peptide dimethylation in patients with prostate cancer.Tumor angiogenesis as prognostic and predictive marker for chemotherapy dose-intensification efficacy in high-risk breast cancer patients within the WSG AM-01 trial.Low endoglin vascular density and Ki67 index in Gleason score 6 tumours may identify prostate cancer patients suitable for surveillance.Approaches to the discovery of non-invasive urinary biomarkers of prostate cancer
P2860
Q24600574-D00A88C9-AE7D-4304-A6A6-E05D4F1C5FC6Q33728841-C574A6A0-9813-4EB4-B763-C0DA6D097F3FQ34614196-DE38585E-A25B-4BA0-8EC2-418382BDED36Q34990214-22990C0F-B784-415B-9D8E-F8EF1C1B8587Q36607766-17419A8C-B59F-4A2B-ACE2-489EE14A8782Q38047103-4B0988A7-4918-4877-AB75-ED98FF5CE220Q38074721-06BFC3F2-C228-4398-8674-08EE39FC0663Q38191924-97449E53-8E73-4B40-8C83-9BB02855B05DQ38613772-D1929B22-2F99-49B7-803C-BF483AB6F086Q39031410-DF1D291C-CCE6-42CB-B0E1-01F41DBC87A4Q41338779-AAADDEF3-6AE4-43E6-9EC7-F4598898EA04Q42483948-A903870E-C3EF-473B-8EA3-76923244E233Q46485766-A2049547-5F6A-48FB-8C47-34E7E6C06007Q57107671-7C1938E0-E6A1-4528-B6F5-9BD05114A951
P2860
Endoglin (CD105) as a urinary and serum marker of prostate cancer
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Endoglin (CD105) as a urinary and serum marker of prostate cancer
@ast
Endoglin (CD105) as a urinary and serum marker of prostate cancer
@en
Endoglin (CD105) as a urinary and serum marker of prostate cancer
@en-gb
Endoglin (CD105) as a urinary and serum marker of prostate cancer
@nl
type
label
Endoglin (CD105) as a urinary and serum marker of prostate cancer
@ast
Endoglin (CD105) as a urinary and serum marker of prostate cancer
@en
Endoglin (CD105) as a urinary and serum marker of prostate cancer
@en-gb
Endoglin (CD105) as a urinary and serum marker of prostate cancer
@nl
prefLabel
Endoglin (CD105) as a urinary and serum marker of prostate cancer
@ast
Endoglin (CD105) as a urinary and serum marker of prostate cancer
@en
Endoglin (CD105) as a urinary and serum marker of prostate cancer
@en-gb
Endoglin (CD105) as a urinary and serum marker of prostate cancer
@nl
P2093
P2860
P356
P1476
Endoglin (CD105) as a urinary and serum marker of prostate cancer
@en
P2093
Charles M Ewing
Christian P Pavlovich
David Y S Chan
Kazutoshi Fujita
Leslie A Mangold
William B Isaacs
P2860
P356
10.1002/IJC.24007
P407
P577
2009-02-01T00:00:00Z